Promising disruptors of p53-MDM2 dimerization from some medicinal plant phytochemicals: a molecular modeling study

References

• Adelusi, T. I., Abdul-Hammed, M., Idris, M. O., Kehinde, O. Q., Boyenle, I. D., Divine, U. C., Adedotun, I. O., Folorunsho, A. A., & Kolawole, O. E. (2021a, June 25). Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches. In Silico Pharmacology, 9(1), 39. https://doi.org/10.1007/s40203-021-00100-2 PMID: 34249600; PMCID: PMC8233444.
   PubMedGoogle Scholar
• Adelusi, T. I., Abdul-Hammed, M., Idris, M. O., Oyedele, Q. K., & Adedotun, I. O. (2021b, June 16). Molecular dynamics, quantum mechanics and docking studies of some Keap1 inhibitors - An insight into the atomistic mechanisms of their antioxidant potential. Heliyon, 7(6), e07317. https://doi.org/10.1016/j.heliyon.2021.e07317 PMID: 34195424; PMCID: PMC8233138.
   PubMed Web of Science ®Google Scholar
• Adelusi, T. I., Abdul-Hammed, M., Ojo, E. M., Oyedele, Q. K., Boyenle, I. D., Adedotun, I. O., Olaoba, O. T., Folorunsho, A. A., & Kolawole, O. E. (2021c). Molecular docking assessment of clinically approved antiviral drugs against Mpro, spike glycoprotein and angiotensin converting enzyme-2 revealed probable anti-SARS-CoV-2 potential. Tropical Journal of Natural Product Research, 5(4)
   Google Scholar
• Adelusi, T. I., Oyedele, A. K., Monday, O. E., Boyenle, I. D., Idris, M. O., Ogunlana, A. T., Ayoola, A. M., Fatoki, J. O., Kolawole, O. E., David, K. B., & Olayemi, A. A. (2021d, November 11). Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro) - molecular dynamics, molecular mechanics, and density functional theory investigations. Journal of Molecular Structure, 1250, 131879. Epub ahead of print. PMID: 34785822; PMCID: PMC8581770. https://doi.org/10.1016/j.molstruc.2021.131879
   PubMed Web of Science ®Google Scholar
• Allen, J. G., Bourbeau, M. P., Wohlhieter, G. E., Bartberger, M. D., Michelsen, K., Hungate, R., Gadwood, R. C., Gaston, R. D., Evans, B., Mann, L. W., Matison, M. E., Schneider, S., Huang, X., Yu, D., Andrews, P. S., Reichelt, A., Long, A. M., Yakowec, P., Yang, E. Y., Lee, T. A., & Oliner, J. D. (2009, November 26). Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction. Journal of Medicinal Chemistry, 52(22), 7044–7053. https://doi.org/10.1021/jm900681h PMID: 19856920.
   PubMed Web of Science ®Google Scholar
• Aparecida Resende, F., de Andrade Barcala, C. A., da Silva Faria, M. C., Kato, F. H., Cunha, W. R., & Tavares, D. C. (2006, August 22). Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice. Life Sciences, 79(13), 1268–1273. https://doi.org/10.1016/j.lfs.2006.03.038 Epub 2006 Apr 7. PMID: 16647723.
   PubMed Web of Science ®Google Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016, June 1). BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007 Epub 2016 May 13. PMID: 27182629; PMCID: PMC4910824.
   PubMed Web of Science ®Google Scholar
• Boyenle, I. D., Divine, U. C., Adeyemi, R., Ayinde, K. S., Olaoba, O. T., Apu, C., Du, L., Lu, Q., Yin, X., & Adelusi, T. I. (2021, May). Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on Insilico perspective. Pharmacological Research, 167, 105577. https://doi.org/10.1016/j.phrs.2021.105577 Epub 2021 Mar 24. PMID: 33774182.
   PubMed Web of Science ®Google Scholar
• Cereto-Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcia-Vallvé, S., & Pujadas, G. (2015). Jan Molecular fingerprint similarity search in virtual screening. Methods (San Diego, Calif.), 71, 58–63. https://doi.org/10.1016/j.ymeth.2014.08.005 Epub 2014 Aug 15. PMID: 25132639.
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, J., Xu, B., Zhu, W., & Li, G. (2011, September). Insight into mechanism of small molecule inhibitors of the MDM2-p53 interaction: Molecular dynamics simulation and free energy analysis. Journal of Molecular Graphics & Modelling, 30, 46–53. https://doi.org/10.1016/j.jmgm.2011.06.003 Epub 2011 Jun 13. PMID: 21764342.
   PubMed Web of Science ®Google Scholar
• Feng, Z., Wu, R., Lin, M., & Hu, W. (2011). Tumor suppressor p53: New functions of an old protein. Frontiers in Biology, 6(1), 58–68. https://doi.org/10.1007/s11515-011-0970-8
   Google Scholar
• Freedman, D. A., Wu, L., & Levine, A. J. (1999, January). Functions of the MDM2 oncoprotein. Cellular and Molecular Life Sciences : CMLS, 55(1), 96–107. https://doi.org/10.1007/s000180050273 PMID: 10065155.
   PubMed Web of Science ®Google Scholar
• Fridman, J. S., & Lowe, S. W. (2003, December 8). Control of apoptosis by p53. Oncogene, 22(56), 9030–9040. https://doi.org/10.1038/sj.onc.1207116 PMID: 14663481.
   PubMed Web of Science ®Google Scholar
• Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009, February). Predicting druggable binding sites at the protein-protein interface. Drug Discovery Today, 14(3–4), 155–161. https://doi.org/10.1016/j.drudis.2008.10.009 Epub 2008 Dec 16. PMID: 19041415.
   PubMed Web of Science ®Google Scholar
• Hainaut, P., & Hollstein, M. (2000). p53 and human cancer: The first ten thousand mutations. Advances in Cancer Research, 77, 81–137. https://doi.org/10.1016/s0065-230x(08)60785-x PMID: 10549356.
   PubMed Web of Science ®Google Scholar
• Hosea, N. A., & Jones, H. M. (2013, April 1). Predicting pharmacokinetic profiles using in silico derived parameters. Molecular Pharmaceutics, 10(4), 1207–1215. https://doi.org/10.1021/mp300482w Epub 2013 Mar 7. PMID: 23427934.
   PubMed Web of Science ®Google Scholar
• Idris, M. O., Yekeen, A. A., Alakanse, O. S., & Durojaye, O. A. (2021, September). Computer-aided screening for potential TMPRSS2 inhibitors: A combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure & Dynamics, 39(15), 5638–5656. https://doi.org/10.1080/07391102.2020.1792346 Epub 2020 Jul 16. PMID: 32672528; PMCID: PMC7441808.
   PubMed Web of Science ®Google Scholar
• Jayaraj, J. M., Reteti, E., Kesavan, C., & Muthusamy, K. (2021, July). Structural insights on vitamin D receptor and screening of new potent agonist molecules: Structure and ligand-based approach. Journal of Biomolecular Structure & Dynamics, 39(11), 4148–4159. https://doi.org/10.1080/07391102.2020.1775122 Epub 2020 Jun 11. PMID: 32462983.
   PubMed Web of Science ®Google Scholar
• Khoutoul, M., Djedouani, A., Lamsayah, M., Abrigach, F., & Touzani, R. (2016). Liquid-liquid extraction of metal ions, DFT and TD-DFT analysis for some pyrane derivatives with high selectivity for Fe (II) and Pb (II). Separation Science and Technology, 51(7), 1112–1123. https://doi.org/10.1080/01496395.2015.1107583
   Web of Science ®Google Scholar
• Kuete, V., Sandjo, L. P., Ouete, J. L., Fouotsa, H., Wiench, B., & Efferth, T. (2014, February 15). Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 21(3), 315–322. https://doi.org/10.1016/j.phymed.2013.08.018 Epub 2013 Sep 24. PMID: 24075210.
   PubMed Web of Science ®Google Scholar
• Kumar, A., & Zhang, K. Y. (2015, January). Hierarchical virtual screening approaches in small molecule drug discovery. Methods (San Diego, Calif.), 71, 26–37. https://doi.org/10.1016/j.ymeth.2014.07.007 Epub 2014 Jul 27. PMID: 25072167; PMCID: PMC7129923.
   PubMed Web of Science ®Google Scholar
• Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996, November 8). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science (New York, N.Y.), 274(5289), 948–953. https://doi.org/10.1126/science.274.5289.948 PMID: 8875929.
   PubMed Web of Science ®Google Scholar
• Lauria, A., Tutone, M., Ippolito, M., Pantano, L., & Almerico, A. M. (2010). Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: The investigation of p53-MDM2 interaction and its inhibition by small molecules. Current Medicinal Chemistry, 17(28), 3142–3154. https://doi.org/10.2174/092986710792232021 PMID: 20666726.
   PubMed Web of Science ®Google Scholar
• Lee, G. R., Shin, W. H., Park, H. B., Shin, S., & Seok, C. (2012). Conformational sampling of flexible ligand-binding protein loops. Bulletin of the Korean Chemical Society, 33(3), 770–774. https://doi.org/10.5012/bkcs.2012.33.3.770
   Web of Science ®Google Scholar
• Lemos, A., Leão, M., Soares, J., Palmeira, A., Pinto, M., Saraiva, L., & Sousa, M. E. (2016, September). Medicinal chemistry strategies to disrupt the p53-MDM2/MDMX interaction. Medicinal Research Reviews, 36(5), 789–844. https://doi.org/10.1002/med.21393 Epub 2016 Jun 15. PMID: 27302609.
   PubMed Web of Science ®Google Scholar
• Liao, K. H., Chen, K. B., Lee, W. Y., Sun, M. F., Lee, C. C., & Chen, C. Y. (2014). Ligand-based and structure-based investigation for Alzheimer's disease from traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine : eCAM, 2014, 364819. https://doi.org/10.1155/2014/364819 Epub 2014 May 8. PMID: 24899907; PMCID: PMC4034731.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001, March 1). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. PMID: 11259830. https://doi.org/10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Liu, K., Watanabe, E., & Kokubo, H. (2017, February). Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. Journal of Computer-Aided Molecular Design, 31(2), 201–211. https://doi.org/10.1007/s10822-016-0005-2 Epub 2017 Jan 10. PMID: 28074360.
   PubMed Web of Science ®Google Scholar
• Lynch T, Price A. (2007). The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.American Family Physician. 2007;76(3):391–396. PMID: 17708140.
   PubMed Web of Science ®Google Scholar
• Menéndez, C. A., Accordino, S. R., Gerbino, D. C., & Appignanesi, G. A. (2016, October 28). Hydrogen bond dynamic propensity studies for protein binding and drug design. PloS One, 11(10), e0165767. https://doi.org/10.1371/journal.pone.0165767 PMID: 27792778; PMCID: PMC5085089.
   PubMed Web of Science ®Google Scholar
• Ohiagu, F. O., Chikezie, P. C., Chikezie, C. M., & Enyoh, C. E. (2021). Anti-cancer activity of Nigerian medicinal plants: A review. Future Journal of Pharmaceautical Sciences, 7.https://doi.org/10.1186/s43094-021-00222-6.
   Google Scholar
• Oke-Altuntas, F., Kapche, G. D. F., Nantchouang Ouete, J. L., Demirtas, I., Koc, M. B., & Ngadjui, B. T. (2016). Bioactivity evaluation of cudraxanthone I, neocyclomorusin and (9bh)-3b-acetoxylanosta-7,24-diene isolated from Milicia excelsaWelw. C. C. Berg (Moraceae). Medicinal Chemistry Research, 25(10), 2250–2257. https://doi.org/10.1007/s00044-016-1670-3
   Web of Science ®Google Scholar
• Okereke, S. C., Ijeh, I. I., & Arunsi, U. O. (2017). Determination of bioactive constituents of RauwolfiavomitoriaAfzel (Asofeyeje) roots using gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectrometry (FT-IR). African Journal of Pharmacy and Pharmacology, 11(2), 25–31. https://doi.org/10.5897/AJPP2016.4712
   Google Scholar
• Ouete, J. L., Sandjo, L. P., Kapche, D. W., Liermann, J. C., Opatz, T., Simo, I. K., & Ngadjui, B. T. (2013, July–August). A new flavone from the roots of Milicia excelsa (Moraceae). Zeitschrift Fur Naturforschung. C, Journal of Biosciences, 68(7–8), 259–263. PMID: 24066509. https://doi.org/10.1515/znc-2013-7-801
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015, May 14). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104 Epub 2015 Apr 22. PMID: 25860834; PMCID: PMC4434528.
   PubMed Web of Science ®Google Scholar
• Rew, Y., Sun, D., Gonzalez-Lopez De Turiso, F., Bartberger, M. D., Beck, H. P., Canon, J., Chen, A., Chow, D., Deignan, J., Fox, B. M., Gustin, D., Huang, X., Jiang, M., Jiao, X., Jin, L., Kayser, F., Kopecky, D. J., Li, Y., Lo, M. C., … Olson, S. H. (2012, June 14). Structure-based design of novel inhibitors of the MDM2-p53 interaction. Journal of Medicinal Chemistry, 55(11), 4936–4954. https://doi.org/10.1021/jm300354j Epub 2012 May 9. PMID: 22524527.
   PubMed Web of Science ®Google Scholar
• Sanguinetti MC, Jiang C, Curran ME, Keating MT. (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81(2):299–307. doi: 10.1016/0092-8674(95)90340-2. PMID: 7736582.
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. (2004, August). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679 Epub 2004 Jul 21. PMID: 15272157.
   PubMedGoogle Scholar
• Simon, L., Imane, A., Srinivasan, K. K., Pathak, L., & Daoud, I. (2017, September). In silico drug-designing studies on flavanoids as anticolon cancer agents: pharmacophore mapping, molecular docking, and Monte Carlo method-based QSAR modeling. Interdisciplinary Sciences, Computational Life Sciences, 9(3), 445–458. https://doi.org/10.1007/s12539-016-0169-4 Epub 2016 Apr 8. PMID: 27059855.
   PubMed Web of Science ®Google Scholar
• Svoboda, G. H., Poore, G. A., Simpson, P. J., & Boder, G. B. (1966, August). Alkaloids of Acronychia Baueri Schott I. Isolation of the alkaloids and a study of the antitumor and other biological properties of acronycine. Journal of Pharmaceutical Sciences, 55(8), 758–768. https://doi.org/10.1002/jps.2600550803 PMID: 5975286.
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010, January 30). AutoDock Vina: iMproving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334 PMID: 19499576; PMCID: PMC3041641.
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005, December). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291 PMID: 16211538.
   PubMed Web of Science ®Google Scholar
• Vassilev, L. T. (2005, July 14). p53 Activation by small molecules: Application in oncology. Journal of Medicinal Chemistry, 48(14), 4491–4499. https://doi.org/10.1021/jm058174k PMID: 15999986.
   PubMed Web of Science ®Google Scholar
• Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., & Liu, E. A. (2004, February 6). In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (New York, N.Y.), 303(5659), 844–848. https://doi.org/10.1126/science.1092472 Epub 2004 Jan 2. PMID: 14704432.
   PubMed Web of Science ®Google Scholar
• Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993, July). The p53-mdm-2 autoregulatory feedback loop. Genes & Development, 7(7A), 1126–1132. https://doi.org/10.1101/gad.7.7a.1126 PMID: 8319905.
   PubMed Web of Science ®Google Scholar
• Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019, March 15). admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics (Oxford, England), 35(6), 1067–1069. https://doi.org/10.1093/bioinformatics/bty707 PMID: 30165565.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., Bernard, D., & Wang, S. (2013). Small molecule inhibitors of MDM2-p53 and MDMX-p53 interactions as new cancer therapeutics. BioDiscovery, 8(8), 4. https://doi.org/10.7750/BioDiscovery.
   Google Scholar